Skip to main content

AbbVie Inc. cash flow statement

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B

In fiscal 2025 (the year to 31 Dec 2025), AbbVie Inc. generated $19.03B of operating cash flow and $17.82B of free cash flow, after $1.21B of capital expenditure.

From AbbVie Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

AbbVie Inc. cash flow statement, annual
USDFY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$3.43B$5.28B$4.13B$1.77B$5.14B$5.95B$5.31B$5.69B$7.88B$4.62B$11.54B$11.84B$4.86B$4.28B$4.23B$10.34B
Depreciation & amortization$1.27B$1.15B$897.0M$786.0M$836.0M$1.19B$1.50B$1.76B$2.02B$6.47B$8.52B$8.47B$8.70B$8.39B$8.14B$7.71B
Stock-based compensation$163.0M$187.0M$212.0M$241.0M$282.0M$353.0M$365.0M$421.0M$430.0M$753.0M$692.0M$671.0M$747.0M$911.0M$955.0M$927.0M
Operating cash flow$6.25B$6.34B$6.27B$3.55B$7.54B$7.04B$9.96B$13.43B$13.32B$17.59B$22.78B$24.94B$22.84B$18.81B$19.03B$20.09B
Operating cash flow margin35.8%34.5%33.4%17.8%33.0%27.5%35.3%41.0%40.1%38.4%40.5%43.0%42.0%33.4%31.1%30.4%
Capital expenditures$356.0M$333.0M$491.0M$612.0M$532.0M$479.0M$529.0M$638.0M$552.0M$798.0M$787.0M$695.0M$777.0M$974.0M$1.21B$1.22B
Acquisitions$273.0M$688.0M$405.0M$622.0M$11.49B$2.50B$0.00$0.00$0.00$38.26B$525.0M$255.0M$0.00$17.49B$204.0M$10.59B
Free cash flow$5.89B$6.01B$5.78B$2.94B$7.00B$6.56B$9.43B$12.79B$12.77B$16.79B$21.99B$24.25B$22.06B$17.83B$17.82B$18.87B
Free cash flow margin33.8%32.7%30.7%14.7%30.6%25.6%33.4%39.0%38.4%36.7%39.1%41.8%40.6%31.7%29.1%28.6%
Free cash flow per share$3.74$3.81$3.60$1.82$4.28$4.02$5.88$8.27$8.61$10.04$12.37$13.64$12.44$10.06$10.05$10.64
Dividends paid——$2.56B$2.66B$3.29B$3.72B$4.11B$5.58B$6.37B$7.72B$9.26B$10.04B$10.54B$11.03B$11.66B$12.14B
Gross share repurchases——$320.0M$665.0M$7.59B$6.03B$1.41B$12.01B$629.0M$978.0M$934.0M$1.49B$1.97B$1.71B$980.0M$1.51B
Stock issuance proceeds——$347.0M$232.0M$155.0M$268.0M$254.0M$73.00M$8.00M$209.0M$244.0M$262.0M$180.0M$214.0M$172.0M—
Net share repurchases——−$27.00M$433.0M$7.43B$5.76B$1.16B$11.94B$621.0M$769.0M$690.0M$1.23B$1.79B$1.49B$808.0M$1.51B
Cash interest paid—$61.00M$283.0M$419.0M$536.0M$986.0M$1.10B$1.22B$1.79B$2.62B$2.71B$2.55B$2.47B$2.81B$3.00B—
Free cash flow after SBC$5.73B$5.83B$5.56B$2.70B$6.72B$6.21B$9.07B$12.37B$12.34B$16.04B$21.30B$23.58B$21.32B$16.92B$16.86B$17.95B

Quarterly

AbbVie Inc. cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$822.0M$1.37B$1.37B$1.56B−$22.00M$1.29B$938.0M$186.0M$1.82B$695.0M$3.61B$4.22B
Depreciation & amortization$2.08B$2.07B$2.08B$2.09B$2.10B$2.04B$2.09B$2.09B$1.99B$1.94B$1.89B$1.89B
Stock-based compensation$125.0M$348.0M$218.0M$181.0M$164.0M$410.0M$179.0M$209.0M$157.0M$444.0M$166.0M$160.0M
Operating cash flow$4.75B$4.04B$2.27B$5.45B$7.05B$1.64B$5.15B$7.02B$5.22B$3.83B$3.44B$7.61B
Operating cash flow margin33.2%32.8%15.7%37.7%46.7%12.3%33.4%44.5%31.4%25.5%20.2%43.7%
Capital expenditures$205.0M$193.0M$241.0M$249.0M$291.0M$235.0M$269.0M$381.0M$329.0M$265.0M$322.0M$301.0M
Acquisitions$0.00$9.20B$0.00$8.29B$0.00$204.0M$0.00$0.00$0.00$0.00$0.00$10.59B
Free cash flow$4.55B$3.85B$2.03B$5.20B$6.76B$1.40B$4.88B$6.64B$4.89B$3.56B$3.11B$7.30B
Free cash flow margin31.8%31.3%14.0%35.9%44.7%10.5%31.7%42.1%29.4%23.8%18.3%42.0%
Free cash flow per share$2.56$2.17$1.15$2.93$3.80$0.79$2.76$3.75$2.75$2.01$1.76$4.12
Dividends paid$2.63B$2.77B$2.75B$2.75B$2.75B$2.92B$2.91B$2.91B$2.91B$3.09B$3.07B$3.07B
Gross share repurchases$3.00M$1.32B$9.00M$17.00M$358.0M$961.0M$12.00M$4.00M$3.00M$1.49B$9.00M$5.00M
Stock issuance proceeds$31.00M$127.0M$10.00M$67.00M$10.00M$56.00M$5.00M$63.00M$48.00M———
Net share repurchases−$28.00M$1.20B−$1.00M−$50.00M$348.0M$905.0M$7.00M−$59.00M−$45.00M$1.49B$9.00M$5.00M
Free cash flow after SBC$4.42B$3.50B$1.81B$5.02B$6.59B$990.0M$4.71B$6.43B$4.73B$3.12B$2.95B$7.14B

The main figures as JSON and plain text. See data and methodology.

ABBV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.